Search for Clinical Trial Results
Plasma Cell Leukemia - 22 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Melphalan, Total Marrow Irradiation, and Autologous Stem Cell Transplantation in Treating Patients With High-Risk Multiple Myeloma Condition:
Interventions:
|
Recruiting |
Study Name: SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy Condition:
|
Recruiting |
Study Name: Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) Condition:
|
Terminated |
Study Name: Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma Condition:
Date: 2012-08-03 Interventions:
|
Completed |
Study Name: Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2005-11-22 Interventions:
|
Recruiting |
Study Name: Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia Condition:
|
Not yet recruiting |
Study Name: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases Condition:
|
Recruiting |
Study Name: Allo HSCT Using RIC for Hematological Diseases Condition:
|
Recruiting |
Study Name: UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep Condition:
|
Recruiting |
Study Name: Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies Condition:
|